News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
119,232 Results
Type
Article (7136)
Company Profile (57)
Press Release (112039)
Section
Business (38170)
Career Advice (87)
Deals (5918)
Drug Delivery (8)
Drug Development (23610)
Employer Resources (12)
FDA (2971)
Job Trends (3559)
News (68589)
Policy (4594)
Tag
Academia (321)
Africa (81)
Alabama (18)
Alliances (11073)
Alzheimer's disease (109)
Antibody-drug conjugate (ADC) (40)
Approvals (2963)
Artificial intelligence (14)
Asia (10210)
Australia (1348)
Bankruptcy (53)
Best Places to Work (3129)
Biosimilars (14)
Biotechnology (48)
Breast cancer (21)
C2C Services and Suppliers (7270)
California (448)
Canada (164)
Cancer (228)
Career advice (74)
CAR-T (26)
Cell therapy (45)
China (49)
Clinical research (18924)
Collaboration (39)
Colorado (11)
Compensation (10)
Connecticut (19)
COVID-19 (293)
Data (57)
Delaware (13)
Diagnostics (1208)
Drug discovery (10)
Earnings (12453)
Employer resources (12)
Europe (18784)
Events (22056)
Executive appointments (38)
FDA (3011)
Florida (52)
Funding (29)
Gene therapy (12)
GLP-1 (89)
Government (459)
Healthcare (4015)
Hotbed/Location (82861)
Illinois (36)
Indiana (18)
Infectious disease (299)
Inflammatory bowel disease (17)
Interviews (11)
IPO (2913)
Job creations (482)
Job search strategy (70)
Layoffs (105)
Legal (466)
Liver cancer (28)
Lung cancer (61)
Lymphoma (11)
Maryland (95)
Massachusetts (378)
Medical device (826)
Medtech (826)
Mergers & acquisitions (2986)
Metabolic disorders (20)
Minnesota (44)
Neuroscience (128)
New Jersey (80)
New York (120)
NextGen Class of 2024 (942)
Non-profit (487)
North Carolina (114)
Northern California (223)
Obesity (10)
Ohio (21)
Opinion (24)
Ovarian cancer (12)
Pancreatic cancer (12)
Pennsylvania (80)
People (12472)
Pharmaceutical (11)
Phase I (7100)
Phase II (8003)
Phase III (6080)
Pipeline (36)
Postmarket research (470)
Preclinical (2185)
Prostate cancer (10)
Real estate (729)
Regulatory (3856)
Research institute (660)
Resumes & cover letters (11)
Series A (11)
South America (108)
Southern California (191)
Startups (752)
Texas (50)
United States (1683)
Vaccines (66)
Washington State (47)
Date
Today (2)
Last 7 days (120)
Last 30 days (486)
Last 365 days (10006)
2024 (6621)
2023 (10645)
2022 (13120)
2021 (13189)
2020 (10973)
2019 (8599)
2018 (6338)
2017 (7129)
2016 (6294)
2015 (6953)
2014 (4526)
2013 (3092)
2012 (3343)
2011 (3334)
2010 (3046)
119,232 Results for "kura oncology".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Beach
Kura Oncology Reports Preclinical Data Supporting Potential for Menin Inhibitor in Diabetes
Kura Oncology, Inc. today reported preclinical data supporting the potential therapeutic utility of menin inhibitors in the treatment of diabetes.
June 24, 2024
·
6 min read
Biotech Beach
Kura Oncology to Participate in Stifel Targeted Oncology Forum
Kura Oncology, Inc. today announced its participation in Stifel 2024 Targeted Oncology Forum.
April 10, 2024
·
2 min read
Biotech Beach
Kura Oncology to Participate in Jefferies Global Healthcare Conference
Kura Oncology, Inc. today announced its participation in Jefferies Global Healthcare Conference. Troy Wilson, Ph.D., J.D., President and Chief Executive Officer, is scheduled to participate in a virtual fireside chat at 3:00 p.m. ET / 12:00 p.m. PT on June 5, 2024.
May 29, 2024
·
1 min read
Biotech Beach
Kura Oncology to Participate in Bank of America Securities 2024 Healthcare Conference
Kura Oncology, Inc., a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, announced its participation in Bank of America Securities 2024 Healthcare Conference.
May 8, 2024
·
1 min read
Business
Kura Oncology Reports First Quarter 2024 Financial Results
Kura Oncology, Inc., a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, reported first quarter 2024 financial results and provided a corporate update.
May 2, 2024
·
11 min read
Business
Kura Oncology to Report First Quarter 2024 Financial Results
Kura Oncology, Inc. today announced that it will report first quarter 2024 financial results after the close of U.S. financial markets on Thursday, May 2, 2024.
April 25, 2024
·
1 min read
Deals
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 7, 2024
Kura Oncology, Inc. today announced that on June 3, 2024, the Compensation Committee of the Company’s Board of Directors (the “Compensation Committee”) granted inducement awards consisting of nonstatutory stock options to purchase 152,500 shares of common stock to eight (8) new employees.
June 7, 2024
·
2 min read
Press Releases
Kura Oncology Reports Second Quarter 2024 Financial Results
August 9, 2024
·
11 min read
Press Releases
Kura Oncology to Report Second Quarter 2024 Financial Results
August 1, 2024
·
2 min read
Biotech Beach
Kura Oncology Completes Enrollment in Registration-Directed Trial of Ziftomenib in NPM1-Mutant AML
Kura Oncology, Inc today announced that it has completed enrollment of 85 patients in the Phase 2 portion of KOMET-001, a registration-directed clinical trial of the Company’s menin inhibitor, ziftomenib (KO-539), in patients with relapsed or refractory (R/R) NPM1-mutant acute myeloid leukemia (AML).
May 14, 2024
·
7 min read
1 of 11,924
Next